Letter to the Editor: Living donor liver transplantation for people with PSC

Melina Heinemann¹, René Adam², Vincent Karam², Christoph Schramm^{1

3

4}

Affiliations

¹ Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² European Liver Transplant Registry, Paul Brousse Hospital, University Paris-Saclay, Villejuif, France.
³ European Reference Network for Hepatological Diseases, Hamburg, Germany.
⁴ Martin Zeitz Center for Rare Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Comment

Melina Heinemann et al. Hepatology. 2023.

. 2023 May 1;77(5):E95-E96.

doi: 10.1097/HEP.0000000000000208. Epub 2023 Jan 3.

Melina Heinemann¹, René Adam², Vincent Karam², Christoph Schramm^{1

3

4}

¹ Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² European Liver Transplant Registry, Paul Brousse Hospital, University Paris-Saclay, Villejuif, France.
³ European Reference Network for Hepatological Diseases, Hamburg, Germany.
⁴ Martin Zeitz Center for Rare Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

No abstract available

Comment in

Reply: Living donor liver transplantation for people with PSC.
Forman LM, Sapisochin G, Assis DN, Arrivé L, Bergquist A, Bowlus CL, Deneau M, Ilyas SI, Lunsford KE, Martinez M, Shroff R, Tabibian JH. Forman LM, et al. Hepatology. 2023 May 1;77(5):E97-E98. doi: 10.1097/HEP.0000000000000210. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36732294 No abstract available.

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. Bowlus CL, et al. Hepatology. 2023 Feb 1;77(2):659-702. doi: 10.1002/hep.32771. Epub 2022 Oct 20. Hepatology. 2023. PMID: 36083140 No abstract available.

1. Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, et al. AASLD Practice Guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2022. doi:10.1002/hep.32771. - DOI
1. Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, et al. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: comparison of risk factors between living and deceased donor recipients. Liver Transpl. 2016;22:1214–1222.
1. Leung KK, Deeb M, Fischer SE, Gulamhusein A. Recurrent primary sclerosing cholangitis: current understanding, management, and future directions. Semin Liver Dis. 2021;41:409–420.
1. Heinemann M, Liwinski T, Adam R, Berenguer M, Mirza D, Malek-Hosseini SA, et al. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: experience from the European Liver Transplant Registry. Am J Transplant. 2022;22:626–633.